z-logo
open-access-imgOpen Access
Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review)
Author(s) -
Mariana Cornelia Tilinca,
Robert Aurelian Tiucă,
Cristiiculas,
Andreea Varga,
Ioan Ţilea
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10601
Subject(s) - semaglutide , molecular medicine , agonist , glucagon like peptide 1 receptor , receptor , oncogene , glucagon like peptide 1 , medicine , cancer research , biology , cell cycle , cancer , endocrinology , diabetes mellitus , type 2 diabetes , liraglutide

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom